(509) 228-1000 WA
(208) 754-3100 ID

Coronavirus (COVID-19) Update: Get the latest information on how we’re responding to the novel coronavirus (COVID-19). CLICK HERE »

Lia Head, MD

Share

back to doctors

Specialty

Medical Oncology and Hematology

Location:

SOUTH SPOKANE

Dr. Head received her MD from the University of Washington in 2016. She went on to complete a residency in internal medicine at the University of Colorado School of Medicine, followed by a fellowship in hematology and oncology at Rush University. Dr. Head has a special interest in lung and gastrointestinal cancers. She believes that every patient is unique and needs an individualized treatment plan that takes in to account the whole person. Dr. Head understands that having cancer is an incredibly scary time in a person’s life. She wants her patients to be active participants in their care, helping them regain some of the control that cancer may have taken away.
 
In her free time, Dr. Head enjoys being on the water, trying new food, and spending valuable time with her son. Her hobbies include puzzles, French bulldogs, and travel.
Education

Medical School:

  • University of Washington School of Medicine; Seattle, WA

 

Residency:

  • University of Colorado School of Medicine (Internal Medicine); Denver, CO

 

Fellowship:

  • Rush University (Hematology Oncology); Chicago, IL
 
Certification
  • American Board of Internal Medicine: Internal Medicine

 

Honors / Leadership
  • Second Place in Poster Contest, Rocky Mountain Society of Hospital Medicine (2018)

  • Research Scholarship recipient, American College of Medical Genetics (2013)

  • Graduated Cum Laude, University of Washington (2011)

 

Memberships
  • American Society of Hematology

  • American Society of Clinical Oncology

 

Peer-Reviewed Articles

Lang J, Capasso A, Jordan KR, French JD, Kar A, Bagby SM, Yacob BW, Head LS, Tompkins KD, Freed BM, Somerset H, Clark TJ, Pitts TM, Messersmith WA, Eckhardt SG, Wierman ME, Leong S, Kiseljak-Vassiliades K. Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment. Journal of Clinical Endocrinology and Metabolism. 2020 Jan 1;105(1).

Head L, Kiseljak-Vassiliades K, Clark TJ, Somerset H, King J, Albuja-Cruz M, Weyant M, Cleveland J, Wierman ME, Leong S. Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer. Journal of Endocrine Society. 2019 Oct;3(12):2295-2304.

Leal AD, Krishnamurthy A, Head L, Messersmith WA. Antibody drug conjugates under investigation in phase 1 and phase II clinical trial for gastrointestinal cancer. Expert Opinion on Investigational Drugs. 2018 Nov; 27(11):901-916.

Anuradha Krishnamurthy, Reed Weiss, Lia Head, Cheryl Lauren Meguid, Sarah Lindsey Davis, Steven Arthur Ahrendt, Wells A. Messersmith, William T. Purcell, Alexis Diane Leal, Karyn A. Goodman, Thor Johnson, Matthew Brown, Megan Boniface, Whitney Herter, Barish H. Edil, Richard D. Schulick, Martin McCarter, Stephen Leong, Christopher Hanyoung Lieu. Impact of Multidisciplinary Management in the Diagnosis and Treatment of Neuroendocrine Tumors. 2018 ASCO Meeting; June 1-5, 2018; Chicago, IL. Abstract e16165.

Palmer MR, McDowall MH, Stewart L, Ouaddi A, MacCoss MJ, Swanson WJ. Mass spectrometry and next-generation sequencing reveal an abundant and rapidly evolving abalone sperm protein. Molecular Reproduction and Development. 2013 Jun;80(6):460-5.